Adults 18 to 85, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Compliance RatePrimary· Baseline through approximately 2 months
Percentage of those in each arm who complete the two visits in the correct order assigned.
Group
Value
95% CI
Dietician / Health Coach
87
66 – 97
Health Coach / Dietician
76
54 – 90
Percentage of Eligible Patients ParticipatingPrimary· One day, during the recruitment period of October 23, 2020 to February 3, 2021.
Percentage of those identified as being eligible who were enrolled in the study.
Group
Value
95% CI
All Eligible Patients
13.1
10.2 – 16.6
Change in Body Mass Index (BMI) at 30 DaysSecondary· 30 days since baseline
Linear trends (or "slopes") for per 30 days are calculated in each group. The slopes were calculated from repeated BMI measurements in each treatment group, and expressed in terms of the change in BMI predicted at 30 days post randomization.
Group
Value
95% CI
Dietician / Health Coach
-0.07
± 0.25
Health Coach / Dietician
-0.16
± 0.20
Sponsor's own description
Randomize Everyone is a research project to develop new informatics systems and statistical methods for supporting randomization processes in EHR systems to do comparative effectiveness research. Two demonstration projects are being conducted in the Dartmouth Hitchcock Medical Center, designed to evaluate different weight loss interventions and common practices in the treatment of chronic low back pain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07403604 — Effect of Insulin Lowering on Lipogenesis
· Phase 1
· recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee
· Phase 3
· recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
· recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart
· Phase 3
· recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl
· Phase 1
· recruiting
Other Dartmouth-Hitchcock Medical Center trials
Trials by the same sponsor.
NCT07325474 — Plan and Protect: Safety Planning for Teens in Rural Emergency Departments
· NA
· not yet recruiting
NCT07428629 — Piloting an Insomnia Treatment in Patients With Ulcerative Colitis
· NA
· not yet recruiting
NCT06777511 — Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients
· not yet recruiting
NCT07279116 — ABY-029 Head & Neck Trial
· Phase 1
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center
Last refreshed: 12 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04514679.